Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimberly Walter

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Cancer Biology & Therapy|June 7, 2008
Genome-wide profiling of methylated promoters in pancreatic adenocarcinomaNoriyuki Omura, Chung-Pin Li, Ang Li, et al.
Cancer Research|January 14, 2016
Activating Mutations in PIK3CB Confer Resistance to PI3K Inhibition and Define a Novel Oncogenic Role for p110βYoshito Nakanishi, Kimberly Walter, Jill M Spoerke, et al.
Epigenomics|March 4, 2014
Discovery and development of DNA methylation-based biomarkers for lung cancerKimberly Walter, Thomas Holcomb, Tom Januario, et al.
Nature Medicine|November 2, 2010
A reductionist cell-free major histocompatibility complex class II antigen processing system identifies immunodominant epitopesIsamu Z Hartman, AeRyon Kim, Robert J Cotter, et al.
Cancer Biology & Therapy|October 4, 2007
Copy-number variants in patients with a strong family history of pancreatic cancerRobert Lucito, Shubha Suresh, Kimberly Walter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2013
Loss of NAPRT1 expression by tumor-specific promoter methylation provides a novel predictive biomarker for NAMPT inhibitorsDavid S Shames, Kristi Elkins, Kimberly Walter, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|December 4, 2013
Integrative analysis of two cell lines derived from a non-small-lung cancer patient--a panomics approachOleg Mayba, Florian Gnad, Michael Peyton, et al.
The American Journal of Pathology|April 12, 2002
Discovery of novel tumor markers of pancreatic cancer using global gene expression technologyChristine A Iacobuzio-Donahue, Anirban Maitra, Grace L Shen-Ong, et al.
Nature Communications|May 14, 2016
Heterogeneity and clinical significance of ESR1 mutations in ER-positive metastatic breast cancer patients receiving fulvestrantJill M Spoerke, Steven Gendreau, Kimberly Walter, et al.
Genome Research|October 4, 2012
Genome and transcriptome sequencing of lung cancers reveal diverse mutational and splicing eventsJinfeng Liu, William Lee, Zhaoshi Jiang, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Cancer Biology & Therapy|June 7, 2008
Genome-wide profiling of methylated promoters in pancreatic adenocarcinomaNoriyuki Omura, Chung-Pin Li, Ang Li, et al.
Cancer Research|January 14, 2016
Activating Mutations in PIK3CB Confer Resistance to PI3K Inhibition and Define a Novel Oncogenic Role for p110βYoshito Nakanishi, Kimberly Walter, Jill M Spoerke, et al.
Epigenomics|March 4, 2014
Discovery and development of DNA methylation-based biomarkers for lung cancerKimberly Walter, Thomas Holcomb, Tom Januario, et al.
Nature Medicine|November 2, 2010
A reductionist cell-free major histocompatibility complex class II antigen processing system identifies immunodominant epitopesIsamu Z Hartman, AeRyon Kim, Robert J Cotter, et al.
Cancer Biology & Therapy|October 4, 2007
Copy-number variants in patients with a strong family history of pancreatic cancerRobert Lucito, Shubha Suresh, Kimberly Walter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2013
Loss of NAPRT1 expression by tumor-specific promoter methylation provides a novel predictive biomarker for NAMPT inhibitorsDavid S Shames, Kristi Elkins, Kimberly Walter, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|December 4, 2013
Integrative analysis of two cell lines derived from a non-small-lung cancer patient--a panomics approachOleg Mayba, Florian Gnad, Michael Peyton, et al.
The American Journal of Pathology|April 12, 2002
Discovery of novel tumor markers of pancreatic cancer using global gene expression technologyChristine A Iacobuzio-Donahue, Anirban Maitra, Grace L Shen-Ong, et al.
Nature Communications|May 14, 2016
Heterogeneity and clinical significance of ESR1 mutations in ER-positive metastatic breast cancer patients receiving fulvestrantJill M Spoerke, Steven Gendreau, Kimberly Walter, et al.
Genome Research|October 4, 2012
Genome and transcriptome sequencing of lung cancers reveal diverse mutational and splicing eventsJinfeng Liu, William Lee, Zhaoshi Jiang, et al.
Pageof 3